0001437749-19-020880.txt : 20191109
0001437749-19-020880.hdr.sgml : 20191109
20191030091055
ACCESSION NUMBER: 0001437749-19-020880
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191029
DATE AS OF CHANGE: 20191030
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rishe Bryan
CENTRAL INDEX KEY: 0001649328
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37799
FILM NUMBER: 191177995
MAIL ADDRESS:
STREET 1: 1331 TYLER STREET NE
STREET 2: SUITE 200
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TACTILE SYSTEMS TECHNOLOGY INC
CENTRAL INDEX KEY: 0001027838
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1331 TYLER STREET NE STE 200
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 866-435-3948
MAIL ADDRESS:
STREET 1: 1331 TYLER STREET NE STE 200
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-10-25
0001027838
TACTILE SYSTEMS TECHNOLOGY INC
TCMD
0001649328
Rishe Bryan
3701 WAYZATA BLVD.
SUITE 300
MINNEAPOLIS
MN
55416
1
SVP, Sales
Common Stock
2019-10-25
4
M
0
4812
0.96
A
50674
D
Common Stock
2019-10-25
4
S
0
4812
44.8836
D
45862
D
Employee Stock Option (right to buy)
0.96
2019-10-25
4
M
0
4812
0
D
2023-10-13
Common Stock
4812
19250
D
Stock option exercises and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2019.
Reflects the weighted average price of 4,812 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on October 25, 2019 with sale prices ranging from $44.47 to $45.35 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Jonathan R. Zimmerman, Attorney-in-Fact
2019-10-29